The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
Open accessAbstract
Objective To characterise the determinants, time course, and risks of acute myocardial infarction associated with use of oral non-steroidal anti-inflammatory drugs (NSAIDs). Design Systematic review followed by a one stage bayesian individual patient data meta-analysis. Data sources Studies from Canadian and European healthcare databases. Review methods Eligible studies were sourced from computerised drug prescription or medical databases, conducted in the general or an elderly population, documented acute myocardial infarction as specific outcome, studied selective cyclo-oxygenase-2 inhibitors (including rofecoxib) and traditional NSAIDs, compared risk of acute myocardial infarction in NSAID users with non-users, allowed for time dependent analyses, and minimised effects of confounding and misclassification bias. Exposure and outcomes Drug exposure was modelled as an indicator variable incorporating the specific NSAID, its recency, duration of use, and dose. The outcome measures were the summary adjusted odds ratios of first acute myocardial infarction after study entry for each category of NSAID use at index date (date of acute myocardial infarction for cases, matched date for controls) versus non-use in the preceding year and the posterior probability of acute myocardial infarction. Results A cohort of 446 763 individuals including 61 460 with acute myocardial infarction was acquired. Taking any dose of NSAIDs for one week, one month, or more than a month was associated with an increased risk of myocardial infarction. With use for one to seven days the probability of increased myocardial infarction risk (posterior probability of odds ratio >1.0) was 92% for celecoxib, 97% for ibuprofen, and 99% for diclofenac, naproxen, and rofecoxib. The corresponding odds ratios (95% credible intervals) were 1.24 (0.91 to 1.82) for celecoxib, 1.48 (1.00 to 2.26) for ibuprofen, 1.50 (1.06 to 2.04) for diclofenac, 1.53 (1.07 to 2.33) for naproxen, and 1.58 (1.07 to 2.17) for rofecoxib. Greater risk of myocardial infarction was documented for higher dose of NSAIDs. With use for longer than one month, risks did not appear to exceed those associated with shorter durations. Conclusions All NSAIDs, including naproxen, were found to be associated with an increased risk of acute myocardial infarction. Risk of myocardial infarction with celecoxib was comparable to that of traditional NSAIDS and was lower than for rofecoxib. Risk was greatest during the first month of NSAID use and with higher doses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Inference from iterative simulation using multiple sequences
Gelman, A., & Rubin, D. B. (1992) · Statistical Science · doi:10.1214/ss/1177011136 · Cited by 16,627
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Causal Diagrams for Epidemiologic Research
Greenland, S., Pearl, J., & Robins, J. M. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00008 · Cited by 3,728
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
Hernán, M. A., & Robins, J. M. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv254 · Cited by 3,115
Air Pollution and Hospital Admissions for Heart Disease in Eight U.S. Counties
Schwartz, J. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00005 · Cited by 3,038
A structural approach to selection bias
Hernán, M. A., Hernández-Díaz, S., & Robins, J. M. (2004) · Epidemiology · doi:10.1097/01.ede.0000135174.63482.43 · Cited by 2,844 · cited 1×
“Selection bias, denoting a common effect of two variables, 53 was not expected to occur since denied access to patient level data was completely independent of findings of acute myocardial infarction in the study.”
BackgroundCardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., Egger, M., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.c7086 · Cited by 1,166
Coca, S. G., Yusuf, B., Shlipak, M. G., Garg, A. X., & Parikh, C. R. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.034 · Cited by 1,161
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Graham, D. J., Campen, D., Hui, R., Spence, M., Cheetham, C., Levy, G., Shoor, S., & Ray, W. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17864-7 · Cited by 913
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Nissen, S. E., Yeomans, N. D., Solomon, D. H., Lüscher, T. F., Libby, P., Husni, M. E., Graham, D. Y., Borer, J. S., Wisniewski, L. M., Wolski, K. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611593 · Cited by 856
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
Johnson, A. G., Nguyen, T. V., & Day, R. O. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00011 · Cited by 717
Tamblyn, R., Lavoie, G., Petrella, L., & Monette, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00234-h · Cited by 577
Hippisley-Cox, J., & Coupland, C. (2005) · BMJ · doi:10.1136/bmj.330.7504.1366 · Cited by 561
BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS
HIGGINS, J. P. T., & WHITEHEAD, A. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961230)15:24<2733::aid-sim562>3.0.co;2-0 · Cited by 557
Raftery, A. E., & Lewis, S. M. (1992) · Statistical Science · doi:10.1214/ss/1177011143 · Cited by 530
Lambert, P. C., Sutton, A. J., Burton, P. R., Abrams, K. R., & Jones, D. R. (2005) · Statistics in Medicine · doi:10.1002/sim.2112 · Cited by 511
Solomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 509
Factors That Can Affect the External Validity of Randomised Controlled Trials
Rothwell, P. M. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010009 · Cited by 376
Eichler, H.-G., Abadie, E., Breckenridge, A., Flamion, B., Gustafsson, L. L., Leufkens, H., Rowland, M., Schneider, C. K., & Bloechl-Daum, B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3501 · Cited by 369
Get real in individual participant data (IPD) meta‐analysis: a review of the methodology
Debray, T. P. A., Moons, K. G. M., van Valkenhoef, G., Efthimiou, O., Hummel, N., Groenwold, R. H. H., Reitsma, J. B., & on behalf of the GetReal methods review group (2015) · Research Synthesis Methods · doi:10.1002/jrsm.1160 · Cited by 348
Pajunen, P., Koukkunen, H., Ketonen, M., Jerkkola, T., Immonen-R??ih??, P., K??rj??-Koskenkari, P., M??h??nen, M., Niemel??, M., Kuulasmaa, K., Palom??ki, P., et al. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200504000-00007 · Cited by 334
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.008 · Cited by 322 · cited 1×
“56 We suspect that residual confounding exists because substantive knowledge 57-59 ascertains that there are mediating intermediate variables on the causal pathway between NSAID exposures and acute myocardial infarction (see fig 1 in web appendix 2).”
BackgroundMamdani, M., Rochon, P., Juurlink, D. N., Anderson, G. M., Kopp, A., Naglie, G., Austin, P. C., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.481 · Cited by 281
Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
Yola, M., & Lucien, A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90170-8 · Cited by 253
Stewart, G. B., Altman, D. G., Askie, L. M., Duley, L., Simmonds, M. C., & Stewart, L. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046042 · Cited by 232
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
Baron, J. A., Sandler, R. S., Bresalier, R. S., Lanas, A., Morton, D. G., Riddell, R., Iverson, E. R., & DeMets, D. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61490-7 · Cited by 232
Association between osteoarthritis and cardiovascular disease: Systematic review and meta-analysis
Hall, A. J., Stubbs, B., Mamas, M. A., Myint, P. K., & Smith, T. O. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315610663 · Cited by 230
Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction
Kimmel, S. E., Berlin, J. A., Reilly, M., Jaskowiak, J., Kishel, L., Chittams, J., & Strom, B. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-3-200502010-00005 · Cited by 222
Evidence Synthesis for Decision Making in Healthcare
Welton, N. J., Sutton, A. J., Cooper, N. J., Abrams, K. R., & Ades, A. E. (2012) · Wiley eBooks · doi:10.1002/9781119942986 · Cited by 216
Pulmonary Diseases and the Heart
Han, M. K., McLaughlin, V. V., Criner, G. J., & Martinez, F. J. (2007) · Circulation · doi:10.1161/circulationaha.106.685206 · Cited by 215
Wettermark, B., Zoëga, H., Furu, K., Korhonen, M., Hallas, J., Nørgaard, M., Almarsdottir, A., Andersen, M., Andersson Sundell, K., Bergman, U., et al. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3457 · Cited by 211
Self-citationHelin-Salmivaara, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl053 · Cited by 211
Self-citationInteractions in epidemiology: relevance, identification, and estimation
Greenland, S. (2009) · Epidemiology · doi:10.1097/ede.0b013e318193e7b5 · Cited by 204
Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage?
Debray, T. P. A., Moons, K. G. M., Abo-Zaid, G. M. A., Koffijberg, H., & Riley, R. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060650 · Cited by 201
Simmonds, M. C., & Higgins, J. P. T. (2007) · Statistics in Medicine · doi:10.1002/sim.2768 · Cited by 194
Jolani, S., Debray, T. P. A., Koffijberg, H., van Buuren, S., & Moons, K. G. M. (2015) · Statistics in Medicine · doi:10.1002/sim.6451 · Cited by 192
Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction.
Levy, A., Tamblyn, R. M., FITCHETT, D. H., McLeod, P. J., & Hanley, J. A. (1999) · PubMed · Cited by 191
Meisinger, C., Döring, A., & Löwel, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi880 · Cited by 187
Fisher, D. J., Copas, A. J., Tierney, J. F., & Parmar, M. K. B. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.11.016 · Cited by 182
Andersohn, F., Suissa, S., & Garbe, E. (2006) · Circulation · doi:10.1161/circulationaha.105.602425 · Cited by 178
Self-citationFlexible modeling of the cumulative effects of time‐dependent exposures on the hazard
Sylvestre, M., & Abrahamowicz, M. (2009) · Statistics in Medicine · doi:10.1002/sim.3701 · Cited by 167
Basic problems in interaction assessment.
Greenland, S. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s459 · Cited by 166
A prior for the variance in hierarchical models
Daniels, M. J. (1999) · Canadian Journal of Statistics · doi:10.2307/3316112 · Cited by 160
Varas‐Lorenzo, C., Riera‐Guàrdia, N., Calingaert, B., Castellsagué, J., Salvo, F., Nicotra, F., Sturkenboom, M., & Perez‐Gutthann, S. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3437 · Cited by 147
Chan, C. C., Reid, C. M., Aw, T., Liew, D., Haas, S. J., & Krum, H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283310dc9 · Cited by 146
Lambert, L., Blais, C., Hamel, D., Brown, K. A., Rinfret, S., Cartier, R., Giguère, M., Carroll, C., Beauchamp, C., & Bogaty, P. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.10.005 · Cited by 128
Schneeweiß, S., Glynn, R. J., Tsai, E. H., Avorn, J., & Solomon, D. H. (2004) · Epidemiology · doi:10.1097/01.ede.0000147164.11879.b5 · Cited by 119
Resche‐Rigon, M., White, I. R., Bartlett, J. W., Peters, S. A. E., Thompson, S. G., & on behalf of the PROG‐IMT Study Group (2013) · Statistics in Medicine · doi:10.1002/sim.5894 · Cited by 114
Varas‐Lorenzo, C., Castellsagué, J., Stang, M. R., Tomas, L., Aguado, J., & Perez‐Gutthann, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1619 · Cited by 107
A review of covariate selection for non‐experimental comparative effectiveness research
Sauer, B. C., Brookhart, M. A., Roy, J., & VanderWeele, T. J. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3506 · Cited by 104
Abraham, N. S., EL‐SERAG, H. B., Hartman, C. M., Richardson, P., & Deswal, A. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03292.x · Cited by 103
Fortier, I., Doiron, D., Little, J., Ferretti, V., L’Heureux, F., Stolk, R. P., Knoppers, B. M., Hudson, T. J., & Burton, P. R. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr106 · Cited by 101
Abrahamowicz, M., Bartlett, G., Tamblyn, R. M., & du Berger, R. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.021 · Cited by 96
Invited Commentary: Consolidating Data Harmonization--How to Obtain Quality and Applicability?
Fortier, I., Doiron, D., Burton, P. R., & Raina, P. S. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr194 · Cited by 90
Hammad, T. A., McAdams‐DeMarco, M., Feight, A. G., Iyasu, S., & Pan, G. J. D. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1672 · Cited by 63
van der Linden, M. W., van der Bij, S., Welsing, P. M. J., Kuipers, E. J., & Herings, R. M. C. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.087254 · Cited by 60
Use of Non-Steroidal Antiinflammatory Drugs and Type-Specific Risk of Acute Coronary Syndrome
Bueno, H., Bardajı́, A., Patrignani, P., Martín‐Merino, E., & García‐Rodríguez, L. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.008 · Cited by 41
Gore, M. R., Sadosky, A., LESLIE, D. L., Tai, K.-S., & Seleznick, M. J. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.019 · Cited by 40
Warren, F. C., Abrams, K. R., Golder, S., & Sutton, A. J. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-64 · Cited by 40
Varas‐Lorenzo, C., Castellsagué, J., Stang, M. R., Perez‐Gutthann, S., Aguado, J., & Rodríguez, L. A. G. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1815 · Cited by 38
Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F., Groves, T., Haileamlak, A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01279-9 · Cited by 35
(2003) · Bayesian Approaches to Clinical Trials and Health‐Care Evaluation · doi:10.1002/0470092602.ch5 · Cited by 26
Mamdani, M., Rochon, P. A., Laupacis, A., et al. (2002) · PubMed · Cited by 26
Adoption of celecoxib and rofecoxib: a nationwide database study
Helin‐Salmivaara, A., Huupponen, R., Virtanen, A., et al. (2005) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2005.00627.x · Cited by 17
Self-citation25 years of pharmacoepidemiologic innovation: the Saskatchewan health administrative databases.
Rawson, N. S. B., Downey, W., Maxwell, C. J., & West, R. (2011) · PubMed · Cited by 10
USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND TYPE-SPECIFIC RISK OF ACUTE CORONARY SYNDROME
Bueno, H., Bardajı́, A., Patrignani, P., Martín‐Merino, E., & García-Rodríguez, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)61574-4 · Cited by 9
Welton, N. J., Sutton, A. J., Cooper, N. J., Abrams, K. R., & Ades, A. E. (2012) · Wiley eBooks · doi:10.1002/9781119942986.ch2 · Cited by 1
Cited by
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis
Bannuru, R. R., Osani, M. C., Vaysbrot, E. E., Arden, N. K., Bennell, K., Bierma-Zeinstra, S. M. A., Kraus, V. B., Lohmander, L. S., Abbott, J. H., Bhandari, M., et al. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.06.011 · Cited by 3,542
Sharma, L. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp1903768 · Cited by 1,073
Novel treatment strategies in rheumatoid arthritis
Burmester, G. R., & Pope, J. E. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31491-5 · Cited by 1,068
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Emerging pharmaceutical therapies for osteoarthritis
Latourte, A., Kloppenburg, M., & Richette, P. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00518-6 · Cited by 418
Metadata
- Authors
- Bally, M., Dendukuri, N., Rich, B., Nadeau, L., Helin-Salmivaara, A., Garbe, E., & Brophy, J. M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2017-05-09
- Volume
- 357
- Pages
- j1909
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- OpenAlex
- W2613818341
- Cited by
- 528
- References
- 75
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.